{ "source": "Vesta research compound reference", "retrieved": "2026-10-30", "note": "Identity data (formula, CAS, CID) were retrieved from PubChem and checked against written sequences; literature entries are PubMed records.", "compounds": [ { "id": "5-amino-1mq", "name": "5-Amino-1MQ", "aliases": [ "5-amino-1-methylquinolinium" ], "type": "small-molecule", "researchArea": "metabolites-and-small-molecules", "components": [], "declaredTotalMgPerVial": null, "formula": "C10H11N2+", "formulaScope": "compound", "monoisotopicMass": 159.0922, "averageMass": 159.21, "identityBasis": "PubChem", "cas": [ "685079-15-6" ], "pubchemCid": 950107, "url": "https://vestapeptides.com/compounds/5-amino-1mq/", "listings": [ { "name": "5-AMINO-1MQ", "sku": "5AM", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 29.85, "url": "https://vestapeptides.com/products/5-amino-1mq-5am/" }, { "name": "5-AMINO-1MQ", "sku": "10AM", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 59.7, "url": "https://vestapeptides.com/products/5-amino-1mq-10am/" }, { "name": "5-AMINO-1MQ", "sku": "50AM", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 119.4, "url": "https://vestapeptides.com/products/5-amino-1mq-50am/" } ], "references": [ { "pmid": "29155147", "title": "Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice.", "journal": "Biochem Pharmacol", "year": "2018" }, { "pmid": "42067476", "title": "Emerging opportunities for nicotinamide N-methyltransferase (NNMT) inhibitor clinical translation.", "journal": "Trends Pharmacol Sci", "year": "2026" } ] }, { "id": "adamax", "name": "Adamax", "aliases": [ "Ac-MEHFPGP-adamantyl" ], "type": "analogue", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C50H69N11O11S", "formulaScope": "compound", "monoisotopicMass": 1031.4899, "averageMass": 1032.21, "identityBasis": "reported formula, unconfirmed", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/adamax/", "listings": [ { "name": "Adamax", "sku": "AX5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/adamax-ax5/" }, { "name": "Adamax", "sku": "AX10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/adamax-ax10/" } ], "references": [] }, { "id": "ahk-cu", "name": "AHK-Cu", "aliases": [ "Alanyl-histidyl-lysine copper" ], "type": "peptide-complex", "researchArea": "copper-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C15H26N6O4", "formulaScope": "AHK peptide component", "monoisotopicMass": 354.2016, "averageMass": 354.4, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "682809-81-0" ], "pubchemCid": 168431292, "url": "https://vestapeptides.com/compounds/ahk-cu/", "listings": [ { "name": "AHK-CU", "sku": "AU50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 29.85, "url": "https://vestapeptides.com/products/ahk-cu-au50/" }, { "name": "AHK-CU", "sku": "AU100", "strengthPerVial": "100 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/ahk-cu-au100/" } ], "references": [ { "pmid": "17703734", "title": "The effect of tripeptide-copper complex on human hair growth in vitro.", "journal": "Arch Pharm Res", "year": "2007" } ] }, { "id": "aod9604", "name": "AOD9604", "aliases": [ "Tyr-hGH 177-191", "AOD-9604" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C78H123N23O23S2", "formulaScope": "compound", "monoisotopicMass": 1813.8604, "averageMass": 1815.08, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "221231-10-3" ], "pubchemCid": 71300630, "url": "https://vestapeptides.com/compounds/aod9604/", "listings": [ { "name": "AOD9604", "sku": "5AD", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 145.52, "url": "https://vestapeptides.com/products/aod9604-5ad/" }, { "name": "AOD9604", "sku": "10AD", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 259.33, "url": "https://vestapeptides.com/products/aod9604-10ad/" } ], "references": [ { "pmid": "15134286", "title": "AOD-9604 Metabolic.", "journal": "Curr Opin Investig Drugs", "year": "2004" }, { "pmid": "25208511", "title": "Detection and in vitro metabolism of AOD9604.", "journal": "Drug Test Anal", "year": "2015" }, { "pmid": "24976118", "title": "Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.", "journal": "Drug Test Anal", "year": "2014" } ] }, { "id": "ara-290", "name": "ARA290", "aliases": [ "Cibinetide", "pHBSP" ], "type": "peptide", "researchArea": "host-defense-and-repair-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C51H84N16O21", "formulaScope": "compound", "monoisotopicMass": 1256.5997, "averageMass": 1257.31, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "1208243-50-8" ], "pubchemCid": 91810664, "url": "https://vestapeptides.com/compounds/ara-290/", "listings": [ { "name": "ARA290", "sku": "RA10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 97.01, "url": "https://vestapeptides.com/products/ara290-ra10/" }, { "name": "ARA290", "sku": "RA16", "strengthPerVial": "16 mg", "vialsPerKit": 10, "priceUsd": 141.79, "url": "https://vestapeptides.com/products/ara290-ra16/" } ], "references": [ { "pmid": "21410562", "title": "The erythropoietin analogue ARA290 modulates the innate immune response and reduces Escherichia coli invasion into urothelial cells.", "journal": "FEMS Immunol Med Microbiol", "year": "2011" }, { "pmid": "29026145", "title": "Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.", "journal": "Sci Rep", "year": "2017" } ] }, { "id": "bpc-157", "name": "BPC-157", "aliases": [ "Body protection compound 157", "Pentadecapeptide BPC 157" ], "type": "peptide", "researchArea": "host-defense-and-repair-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C62H98N16O22", "formulaScope": "compound", "monoisotopicMass": 1418.7042, "averageMass": 1419.54, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "137525-51-0" ], "pubchemCid": 9941957, "url": "https://vestapeptides.com/compounds/bpc-157/", "listings": [ { "name": "BPC 157", "sku": "BC5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 59.7, "url": "https://vestapeptides.com/products/bpc-157-bc5/" }, { "name": "BPC 157", "sku": "BC10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 83.96, "url": "https://vestapeptides.com/products/bpc-157-bc10/" }, { "name": "BPC 157", "sku": "BC20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 134.33, "url": "https://vestapeptides.com/products/bpc-157-bc20/" }, { "name": "BPC 5mg+TB5mg", "sku": "BB10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 113.81, "url": "https://vestapeptides.com/products/bpc-5mg-tb5mg-bb10/" }, { "name": "BPC 10mg+TB10mg", "sku": "BB20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 171.64, "url": "https://vestapeptides.com/products/bpc-10mg-tb10mg-bb20/" }, { "name": "BPC 15mg+TB15mg", "sku": "BB30", "strengthPerVial": "30 mg", "vialsPerKit": 10, "priceUsd": 223.88, "url": "https://vestapeptides.com/products/bpc-15mg-tb15mg-bb30/" }, { "name": "BPC 20mg+TB20mg", "sku": "BB40", "strengthPerVial": "40 mg", "vialsPerKit": 10, "priceUsd": 279.85, "url": "https://vestapeptides.com/products/bpc-20mg-tb20mg-bb40/" }, { "name": "GLOW", "sku": "Glow70", "strengthPerVial": "70 mg", "vialsPerKit": 10, "priceUsd": 208.96, "url": "https://vestapeptides.com/products/glow-glow70/" }, { "name": "Klow", "sku": "Klow80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/klow-klow80/" } ], "references": [ { "pmid": "34267654", "title": "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.", "journal": "Front Pharmacol", "year": "2021" }, { "pmid": "40789979", "title": "Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.", "journal": "Curr Rev Musculoskelet Med", "year": "2025" }, { "pmid": "14554208", "title": "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.", "journal": "J Orthop Res", "year": "2003" } ] }, { "id": "cagrilintide", "name": "Cagrilintide", "aliases": [ "NN9838" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C194H312N54O59S2", "formulaScope": "compound", "monoisotopicMass": 4406.2515, "averageMass": 4409.01, "identityBasis": "PubChem", "cas": [ "1415456-99-3" ], "pubchemCid": 171397054, "url": "https://vestapeptides.com/compounds/cagrilintide/", "listings": [ { "name": "Cagrilintide", "sku": "CGL5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 113.81, "url": "https://vestapeptides.com/products/cagrilintide-cgl5/" }, { "name": "Cagrilintide", "sku": "CGL10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 197.76, "url": "https://vestapeptides.com/products/cagrilintide-cgl10/" }, { "name": "Cagri+Semaglutide", "sku": "CS5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 111.94, "url": "https://vestapeptides.com/products/cagri-semaglutide-cs5/" }, { "name": "Cagri+Semaglutide", "sku": "CS10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 158.58, "url": "https://vestapeptides.com/products/cagri-semaglutide-cs10/" }, { "name": "Cagri+Semaglutide", "sku": "CS20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 257.46, "url": "https://vestapeptides.com/products/cagri-semaglutide-cs20/" }, { "name": "Cagri+Tirzepatide", "sku": "TRC10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 160.45, "url": "https://vestapeptides.com/products/cagri-tirzepatide-trc10/" }, { "name": "Cagri+Tirzepatide", "sku": "TRC20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 263.06, "url": "https://vestapeptides.com/products/cagri-tirzepatide-trc20/" } ], "references": [ { "pmid": "34288673", "title": "Development of Cagrilintide, a Long-Acting Amylin Analogue.", "journal": "J Med Chem", "year": "2021" }, { "pmid": "40204768", "title": "Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.", "journal": "Nat Commun", "year": "2025" }, { "pmid": "40609154", "title": "Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.", "journal": "EBioMedicine", "year": "2025" } ] }, { "id": "cartalax", "name": "Cartalax", "aliases": [ "AED", "Ala-Glu-Asp" ], "type": "peptide", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C12H19N3O8", "formulaScope": "compound", "monoisotopicMass": 333.1172, "averageMass": 333.29, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "85806-95-7" ], "pubchemCid": 87815447, "url": "https://vestapeptides.com/compounds/cartalax/", "listings": [ { "name": "Cartalax", "sku": "Cartalax", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 123.13, "url": "https://vestapeptides.com/products/cartalax-cartalax/" } ], "references": [ { "pmid": "12374906", "title": "Peptides and Ageing.", "journal": "Neuro Endocrinol Lett", "year": "2002" } ] }, { "id": "cjc-1295", "name": "CJC-1295", "aliases": [ "Modified GRF(1-29)", "CJC-1295 DAC", "DAC:GRF" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C165H269N47O46", "formulaScope": "compound", "monoisotopicMass": 3645.0155, "averageMass": 3647.19, "identityBasis": "PubChem", "cas": [ "446262-90-4" ], "pubchemCid": 91971820, "url": "https://vestapeptides.com/compounds/cjc-1295/", "listings": [ { "name": "CJC1295 with DAC", "sku": "CD5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 216.42, "url": "https://vestapeptides.com/products/cjc1295-with-dac-cd5/" }, { "name": "CJC1295 with DAC", "sku": "CD10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 391.79, "url": "https://vestapeptides.com/products/cjc1295-with-dac-cd10/" }, { "name": "CJC1295 no DAC", "sku": "CND5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 98.88, "url": "https://vestapeptides.com/products/cjc1295-no-dac-cnd5/" }, { "name": "CJC1295 no DAC", "sku": "CND10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 167.91, "url": "https://vestapeptides.com/products/cjc1295-no-dac-cnd10/" }, { "name": "CJC1295+Ipamorelin", "sku": "CP10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 141.79, "url": "https://vestapeptides.com/products/cjc1295-ipamorelin-cp10/" }, { "name": "CJC1295+Ipamorelin", "sku": "CP20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 263.06, "url": "https://vestapeptides.com/products/cjc1295-ipamorelin-cp20/" } ], "references": [ { "pmid": "21204297", "title": "Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation.", "journal": "Drug Test Anal", "year": "2010" }, { "pmid": "19386527", "title": "Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.", "journal": "Growth Horm IGF Res", "year": "2009" }, { "pmid": "16352683", "title": "Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.", "journal": "J Clin Endocrinol Metab", "year": "2006" } ] }, { "id": "dihexa", "name": "Dihexa", "aliases": [ "PNB-0408", "N-hexanoic-Tyr-Ile-(6) aminohexanoic amide" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C27H44N4O5", "formulaScope": "compound", "monoisotopicMass": 504.3312, "averageMass": 504.66, "identityBasis": "PubChem", "cas": [ "1401708-83-5" ], "pubchemCid": 129010512, "url": "https://vestapeptides.com/compounds/dihexa/", "listings": [ { "name": "Dihexa", "sku": "DIH5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 41.04, "url": "https://vestapeptides.com/products/dihexa-dih5/" }, { "name": "Dihexa", "sku": "DIH10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 52.24, "url": "https://vestapeptides.com/products/dihexa-dih10/" } ], "references": [ { "pmid": "25187433", "title": "The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.", "journal": "J Pharmacol Exp Ther", "year": "2014" }, { "pmid": "34827486", "title": "AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway.", "journal": "Brain Sci", "year": "2021" } ] }, { "id": "epithalon", "name": "Epithalon", "aliases": [ "Epitalon", "Ala-Glu-Asp-Gly" ], "type": "peptide", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C14H22N4O9", "formulaScope": "compound", "monoisotopicMass": 390.1387, "averageMass": 390.35, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "307297-39-8", "64082-79-7" ], "pubchemCid": 219042, "url": "https://vestapeptides.com/compounds/epithalon/", "listings": [ { "name": "Epithalon", "sku": "ET10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/epithalon-et10/" }, { "name": "Epithalon", "sku": "ET50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 238.81, "url": "https://vestapeptides.com/products/epithalon-et50/" } ], "references": [ { "pmid": "40141333", "title": "Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.", "journal": "Int J Mol Sci", "year": "2025" }, { "pmid": "12937682", "title": "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.", "journal": "Bull Exp Biol Med", "year": "2003" } ] }, { "id": "ghk-cu", "name": "GHK-Cu", "aliases": [ "Copper tripeptide-1", "Glycyl-L-histidyl-L-lysine copper" ], "type": "peptide-complex", "researchArea": "copper-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C14H24N6O4", "formulaScope": "GHK peptide component", "monoisotopicMass": 340.1859, "averageMass": 340.38, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [], "pubchemCid": 139035031, "url": "https://vestapeptides.com/compounds/ghk-cu/", "listings": [ { "name": "GHK-Cu", "sku": "CU50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 22.39, "url": "https://vestapeptides.com/products/ghk-cu-cu50/" }, { "name": "GHK-Cu", "sku": "CU100", "strengthPerVial": "100 mg", "vialsPerKit": 10, "priceUsd": 37.31, "url": "https://vestapeptides.com/products/ghk-cu-cu100/" }, { "name": "GLOW", "sku": "Glow70", "strengthPerVial": "70 mg", "vialsPerKit": 10, "priceUsd": 208.96, "url": "https://vestapeptides.com/products/glow-glow70/" }, { "name": "Klow", "sku": "Klow80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/klow-klow80/" } ], "references": [ { "pmid": "29986520", "title": "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.", "journal": "Int J Mol Sci", "year": "2018" }, { "pmid": "33263328", "title": "The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography.", "journal": "Acta Crystallogr D Struct Biol", "year": "2020" }, { "pmid": "32371360", "title": "Theoretical study of copper binding to GHK peptide.", "journal": "Comput Biol Chem", "year": "2020" } ] }, { "id": "ghrp-2", "name": "GHRP-2", "aliases": [ "Pralmorelin", "KP-102" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C45H55N9O6", "formulaScope": "compound", "monoisotopicMass": 817.4275, "averageMass": 817.97, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "158861-67-7" ], "pubchemCid": 6918245, "url": "https://vestapeptides.com/compounds/ghrp-2/", "listings": [ { "name": "GHRP-2 Acetate", "sku": "G25", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/ghrp-2-acetate-g25/" }, { "name": "GHRP-2 Acetate", "sku": "G210", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 97.01, "url": "https://vestapeptides.com/products/ghrp-2-acetate-g210/" }, { "name": "GHRP-2 Acetate", "sku": "G215", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 128.73, "url": "https://vestapeptides.com/products/ghrp-2-acetate-g215/" } ], "references": [ { "pmid": "15646370", "title": "Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.", "journal": "Arzneimittelforschung", "year": "2004" }, { "pmid": "20552695", "title": "Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.", "journal": "Rapid Commun Mass Spectrom", "year": "2010" } ] }, { "id": "ghrp-6", "name": "GHRP-6", "aliases": [ "Growth hormone releasing peptide-6" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C46H56N12O6", "formulaScope": "compound", "monoisotopicMass": 872.4446, "averageMass": 873.01, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [], "pubchemCid": 4345065, "url": "https://vestapeptides.com/compounds/ghrp-6/", "listings": [ { "name": "GHRP-6 Acetate", "sku": "G65", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/ghrp-6-acetate-g65/" }, { "name": "GHRP-6 Acetate", "sku": "G610", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 95.15, "url": "https://vestapeptides.com/products/ghrp-6-acetate-g610/" }, { "name": "GHRP-6 Acetate", "sku": "G615", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 128.73, "url": "https://vestapeptides.com/products/ghrp-6-acetate-g615/" } ], "references": [ { "pmid": "7920995", "title": "Regulation of growth hormone secretion by the growth hormone releasing hexapeptide (GHRP-6).", "journal": "J Pediatr Endocrinol", "year": "1993" }, { "pmid": "17481583", "title": "Ghrelin and GHRP-6 enhance electrical and secretory activity in GC somatotropes.", "journal": "Biochem Biophys Res Commun", "year": "2007" }, { "pmid": "25809000", "title": "Detection of GHRP-2 and GHRP-6 in urine samples from athletes.", "journal": "Drug Test Anal", "year": "2015" } ] }, { "id": "glow", "name": "GLOW", "aliases": [ "GLOW 70 mg blend" ], "type": "blend", "researchArea": "multi-component-formulations", "components": [ { "id": "ghk-cu", "name": "GHK-Cu", "declaredMg": 50, "formula": "C14H24N6O4", "averageMass": 340.38, "monoisotopicMass": 340.1859 }, { "id": "bpc-157", "name": "BPC-157", "declaredMg": 10, "formula": "C62H98N16O22", "averageMass": 1419.54, "monoisotopicMass": 1418.7042 }, { "id": "thymosin-beta-4", "name": "TB-500 (thymosin beta-4)", "declaredMg": 10, "formula": "C212H350N56O78S", "averageMass": 4963.44, "monoisotopicMass": 4960.4863 } ], "declaredTotalMgPerVial": 70, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/glow/", "listings": [ { "name": "GLOW", "sku": "Glow70", "strengthPerVial": "70 mg", "vialsPerKit": 10, "priceUsd": 208.96, "url": "https://vestapeptides.com/products/glow-glow70/" } ], "references": [] }, { "id": "glutathione", "name": "Glutathione", "aliases": [ "GSH", "L-γ-Glutamyl-L-cysteinylglycine" ], "type": "small-molecule", "researchArea": "metabolites-and-small-molecules", "components": [], "declaredTotalMgPerVial": null, "formula": "C10H17N3O6S", "formulaScope": "compound", "monoisotopicMass": 307.0838, "averageMass": 307.32, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "70-18-8", "106272-20-2" ], "pubchemCid": 124886, "url": "https://vestapeptides.com/compounds/glutathione/", "listings": [ { "name": "Glutathione", "sku": "GTT600", "strengthPerVial": "600 mg", "vialsPerKit": 10, "priceUsd": 48.51, "url": "https://vestapeptides.com/products/glutathione-gtt600/" }, { "name": "Glutathione", "sku": "GTT1500", "strengthPerVial": "1500 mg", "vialsPerKit": 10, "priceUsd": 82.09, "url": "https://vestapeptides.com/products/glutathione-gtt1500/" } ], "references": [ { "pmid": "6137189", "title": "Glutathione.", "journal": "Annu Rev Biochem", "year": "1983" }, { "pmid": "7651209", "title": "Glutathione metabolism.", "journal": "Methods Enzymol", "year": "1995" } ] }, { "id": "gonadorelin", "name": "Gonadorelin", "aliases": [ "GnRH", "LHRH" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C55H75N17O13", "formulaScope": "compound", "monoisotopicMass": 1181.573, "averageMass": 1182.29, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "33515-09-2" ], "pubchemCid": 638793, "url": "https://vestapeptides.com/compounds/gonadorelin/", "listings": [ { "name": "Gonadorelin", "sku": "GND2", "strengthPerVial": "2 mg", "vialsPerKit": 10, "priceUsd": 48.51, "url": "https://vestapeptides.com/products/gonadorelin-gnd2/" }, { "name": "Gonadorelin", "sku": "GND5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 78.36, "url": "https://vestapeptides.com/products/gonadorelin-gnd5/" } ], "references": [ { "pmid": "36858006", "title": "Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin.", "journal": "J Pharm Biomed Anal", "year": "2023" }, { "pmid": "31309882", "title": "Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development.", "journal": "Curr Med Chem", "year": "2020" } ] }, { "id": "hexarelin", "name": "Hexarelin", "aliases": [ "Examorelin" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C47H58N12O6", "formulaScope": "compound", "monoisotopicMass": 886.4602, "averageMass": 887.04, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "140703-51-1", "208251-52-9" ], "pubchemCid": 6918297, "url": "https://vestapeptides.com/compounds/hexarelin/", "listings": [ { "name": "Hexarelin", "sku": "HX2", "strengthPerVial": "2 mg", "vialsPerKit": 10, "priceUsd": 69.03, "url": "https://vestapeptides.com/products/hexarelin-hx2/" }, { "name": "Hexarelin", "sku": "HX5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 128.73, "url": "https://vestapeptides.com/products/hexarelin-hx5/" } ], "references": [ { "pmid": "25278975", "title": "The cardiovascular action of hexarelin.", "journal": "J Geriatr Cardiol", "year": "2014" }, { "pmid": "25645463", "title": "Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.", "journal": "Endocrine", "year": "2015" } ] }, { "id": "igf-1-lr3", "name": "IGF-1 LR3", "aliases": [ "Long R3 IGF-I", "LR3-IGF-1" ], "type": "protein", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C400H619N111O115S9", "formulaScope": "compound", "monoisotopicMass": 9105.3487, "averageMass": 9111.45, "identityBasis": "calculated from sequence", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/igf-1-lr3/", "listings": [ { "name": "IGF-1 LR3", "sku": "IG01", "strengthPerVial": "100 mcg", "vialsPerKit": 10, "priceUsd": 54.1, "url": "https://vestapeptides.com/products/igf-1-lr3-ig01/" }, { "name": "IGF-1 LR3", "sku": "IG1", "strengthPerVial": "1 mg", "vialsPerKit": 10, "priceUsd": 317.16, "url": "https://vestapeptides.com/products/igf-1-lr3-ig1/" } ], "references": [ { "pmid": "37261455", "title": "Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris.", "journal": "Appl Microbiol Biotechnol", "year": "2023" }, { "pmid": "11999215", "title": "Effects of insulin-like growth factor-I and its analogue, long-R3-IGF-I, on intestinal absorption of 3-O-methyl-D-glucose are less pronounced than gut mucosal growth responses.", "journal": "Growth Factors", "year": "2002" } ] }, { "id": "ipamorelin", "name": "Ipamorelin", "aliases": [ "NNC 26-0161" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C38H49N9O5", "formulaScope": "compound", "monoisotopicMass": 711.3857, "averageMass": 711.85, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "170851-70-4" ], "pubchemCid": 9831659, "url": "https://vestapeptides.com/compounds/ipamorelin/", "listings": [ { "name": "Ipamorelin", "sku": "IP5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/ipamorelin-ip5/" }, { "name": "Ipamorelin", "sku": "IP10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 89.55, "url": "https://vestapeptides.com/products/ipamorelin-ip10/" }, { "name": "CJC1295+Ipamorelin", "sku": "CP10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 141.79, "url": "https://vestapeptides.com/products/cjc1295-ipamorelin-cp10/" }, { "name": "CJC1295+Ipamorelin", "sku": "CP20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 263.06, "url": "https://vestapeptides.com/products/cjc1295-ipamorelin-cp20/" }, { "name": "Tesamorelin10mg+Ipamorelin5mg", "sku": "TI", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/tesamorelin10mg-ipamorelin5mg-ti/" } ], "references": [ { "pmid": "9849822", "title": "Ipamorelin, the first selective growth hormone secretagogue.", "journal": "Eur J Endocrinol", "year": "1998" }, { "pmid": "9879640", "title": "Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.", "journal": "Xenobiotica", "year": "1998" }, { "pmid": "11459660", "title": "Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.", "journal": "Bioorg Med Chem Lett", "year": "2001" } ] }, { "id": "kisspeptin-10", "name": "Kisspeptin-10", "aliases": [ "Metastin 45-54" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C63H83N17O14", "formulaScope": "compound", "monoisotopicMass": 1301.6305, "averageMass": 1302.44, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "374675-21-5" ], "pubchemCid": 25240297, "url": "https://vestapeptides.com/compounds/kisspeptin-10/", "listings": [ { "name": "Kisspeptin-10", "sku": "KS5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/kisspeptin-10-ks5/" }, { "name": "Kisspeptin-10", "sku": "KS10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/kisspeptin-10-ks10/" } ], "references": [ { "pmid": "39813600", "title": "Kisspeptin and neurokinin B: roles in reproductive health.", "journal": "Physiol Rev", "year": "2025" }, { "pmid": "35837314", "title": "The Role of Kisspeptin in the Control of the Hypothalamic-Pituitary-Gonadal Axis and Reproduction.", "journal": "Front Endocrinol (Lausanne)", "year": "2022" }, { "pmid": "15020672", "title": "Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts.", "journal": "J Cell Sci", "year": "2004" } ] }, { "id": "klow", "name": "Klow", "aliases": [ "Klow 80 mg blend" ], "type": "blend", "researchArea": "multi-component-formulations", "components": [ { "id": "ghk-cu", "name": "GHK-Cu", "declaredMg": 50, "formula": "C14H24N6O4", "averageMass": 340.38, "monoisotopicMass": 340.1859 }, { "id": "bpc-157", "name": "BPC-157", "declaredMg": 10, "formula": "C62H98N16O22", "averageMass": 1419.54, "monoisotopicMass": 1418.7042 }, { "id": "thymosin-beta-4", "name": "TB-500 (thymosin beta-4)", "declaredMg": 10, "formula": "C212H350N56O78S", "averageMass": 4963.44, "monoisotopicMass": 4960.4863 }, { "id": "kpv", "name": "KPV", "declaredMg": 10, "formula": "C16H30N4O4", "averageMass": 342.43, "monoisotopicMass": 342.2267 } ], "declaredTotalMgPerVial": 80, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/klow/", "listings": [ { "name": "Klow", "sku": "Klow80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/klow-klow80/" } ], "references": [] }, { "id": "kpv", "name": "KPV", "aliases": [ "α-MSH(11-13)", "Lys-Pro-Val" ], "type": "peptide", "researchArea": "host-defense-and-repair-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C16H30N4O4", "formulaScope": "compound", "monoisotopicMass": 342.2267, "averageMass": 342.43, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "67727-97-3" ], "pubchemCid": 125672, "url": "https://vestapeptides.com/compounds/kpv/", "listings": [ { "name": "KPV", "sku": "KP5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 44.78, "url": "https://vestapeptides.com/products/kpv-kp5/" }, { "name": "KPV", "sku": "KP10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/kpv-kp10/" }, { "name": "Klow", "sku": "Klow80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/klow-klow80/" } ], "references": [ { "pmid": "12750433", "title": "Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.", "journal": "J Pharmacol Exp Ther", "year": "2003" }, { "pmid": "25298219", "title": "Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates.", "journal": "Biomed Chromatogr", "year": "2015" } ] }, { "id": "l-carnitine", "name": "L-carnitine", "aliases": [ "Levocarnitine" ], "type": "small-molecule", "researchArea": "metabolites-and-small-molecules", "components": [], "declaredTotalMgPerVial": null, "formula": "C7H15NO3", "formulaScope": "compound", "monoisotopicMass": 161.1052, "averageMass": 161.2, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "541-15-1", "44985-71-9" ], "pubchemCid": 10917, "url": "https://vestapeptides.com/compounds/l-carnitine/", "listings": [ { "name": "L-carnitine", "sku": "LC400", "strengthPerVial": "400 mg", "vialsPerKit": 10, "priceUsd": 44.78, "url": "https://vestapeptides.com/products/l-carnitine-lc400/" }, { "name": "L-carnitine", "sku": "LC600", "strengthPerVial": "600 mg", "vialsPerKit": 10, "priceUsd": 52.24, "url": "https://vestapeptides.com/products/l-carnitine-lc600/" }, { "name": "L-carnitine", "sku": "LC1200", "strengthPerVial": "1200 mg", "vialsPerKit": 10, "priceUsd": 78.36, "url": "https://vestapeptides.com/products/l-carnitine-lc1200/" } ], "references": [ { "pmid": "21561431", "title": "L-carnitine--metabolic functions and meaning in humans life.", "journal": "Curr Drug Metab", "year": "2011" } ] }, { "id": "lemon-bottle", "name": "Lemon Bottle", "aliases": [ "Lemon Bottle lipolytic complex" ], "type": "mixture", "researchArea": "multi-component-formulations", "components": [ { "id": "riboflavin", "name": "Riboflavin (vitamin B2)", "declaredMg": null, "formula": "C17H20N4O6", "averageMass": 376.36, "monoisotopicMass": 376.1383 }, { "name": "Bromelain", "note": "a mixture of cysteine proteases from pineapple, measured by enzyme activity rather than by mass" }, { "name": "Lecithin", "note": "a mixture of phospholipids in which phosphatidylcholine usually predominates" } ], "declaredTotalMgPerVial": null, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/lemon-bottle/", "listings": [ { "name": "Lemon Bottle", "sku": "LB", "strengthPerVial": "10 mL", "vialsPerKit": 10, "priceUsd": 44.78, "url": "https://vestapeptides.com/products/lemon-bottle-lb/" } ], "references": [] }, { "id": "lipo-c", "name": "Lipo-C", "aliases": [ "Lipo C", "Lipo-C FatBlaster", "LC533", "Lipolytic complex", "Lipo-C blends" ], "type": "mixture", "researchArea": "multi-component-formulations", "components": [], "declaredTotalMgPerVial": null, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/lipo-c/", "listings": [ { "name": "Lipo-c", "sku": "LC120", "strengthPerVial": "10 mL", "vialsPerKit": 10, "priceUsd": 44.78, "url": "https://vestapeptides.com/products/lipo-c-lc120/" }, { "name": "Lipo-C(FatBlaster)", "sku": "LC526", "strengthPerVial": "10 mL", "vialsPerKit": 10, "priceUsd": 89.55, "url": "https://vestapeptides.com/products/lipo-c-fatblaster-lc526/" }, { "name": "LC533", "sku": "LC533", "strengthPerVial": "10 mL", "vialsPerKit": 10, "priceUsd": 126.87, "url": "https://vestapeptides.com/products/lc533-lc533/" } ], "references": [] }, { "id": "mic-b12", "name": "Lipo-C with B12 (MIC)", "aliases": [ "Lipo C with B12", "MIC B12", "Methionine inositol choline B12" ], "type": "mixture", "researchArea": "multi-component-formulations", "components": [ { "id": "l-methionine", "name": "L-Methionine", "declaredMg": null, "formula": "C5H11NO2S", "averageMass": 149.21, "monoisotopicMass": 149.051 }, { "id": "myo-inositol", "name": "myo-Inositol", "declaredMg": null, "formula": "C6H12O6", "averageMass": 180.16, "monoisotopicMass": 180.0634 }, { "id": "choline-chloride", "name": "Choline chloride", "declaredMg": null, "formula": "C5H14ClNO", "averageMass": 139.62, "monoisotopicMass": 139.0764 }, { "id": "cyanocobalamin", "name": "Cyanocobalamin (vitamin B12)", "declaredMg": null, "formula": "C63H88CoN14O14P", "averageMass": 1355.37, "monoisotopicMass": 1354.5674 } ], "declaredTotalMgPerVial": null, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/mic-b12/", "listings": [ { "name": "Lipo C with B12", "sku": "MIC", "strengthPerVial": "10 mL", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/lipo-c-with-b12-mic/" } ], "references": [] }, { "id": "liraglutide", "name": "Liraglutide", "aliases": [ "NN2211" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C172H265N43O51", "formulaScope": "compound", "monoisotopicMass": 3748.9465, "averageMass": 3751.2, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "204656-20-2" ], "pubchemCid": 16134956, "url": "https://vestapeptides.com/compounds/liraglutide/", "listings": [ { "name": "Liraglutide", "sku": "LIR5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 55.97, "url": "https://vestapeptides.com/products/liraglutide-lir5/" }, { "name": "Liraglutide", "sku": "LIR10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 83.96, "url": "https://vestapeptides.com/products/liraglutide-lir10/" } ], "references": [ { "pmid": "31031702", "title": "The Discovery and Development of Liraglutide and Semaglutide.", "journal": "Front Endocrinol (Lausanne)", "year": "2019" }, { "pmid": "25202980", "title": "The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.", "journal": "J Clin Invest", "year": "2014" } ] }, { "id": "ll-37", "name": "LL-37", "aliases": [ "Cathelicidin LL-37", "hCAP18(134-170)" ], "type": "peptide", "researchArea": "host-defense-and-repair-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C205H340N60O53", "formulaScope": "compound", "monoisotopicMass": 4490.5754, "averageMass": 4493.26, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "154947-66-7" ], "pubchemCid": 16198951, "url": "https://vestapeptides.com/compounds/ll-37/", "listings": [ { "name": "LL37", "sku": "LL37", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 138.06, "url": "https://vestapeptides.com/products/ll37-ll37/" } ], "references": [ { "pmid": "32753597", "title": "The Human LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure.", "journal": "Nat Commun", "year": "2020" }, { "pmid": "14978805", "title": "The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I.", "journal": "Rapid Commun Mass Spectrom", "year": "2004" } ] }, { "id": "mazdutide", "name": "Mazdutide", "aliases": [ "IBI362", "LY3305677" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C207H317N45O65", "formulaScope": "compound", "monoisotopicMass": 4473.2883, "averageMass": 4475.99, "identityBasis": "PubChem", "cas": [ "2259884-03-0" ], "pubchemCid": 167312357, "url": "https://vestapeptides.com/compounds/mazdutide/", "listings": [ { "name": "Mazdutide", "sku": "MZ5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 205.22, "url": "https://vestapeptides.com/products/mazdutide-mz5/" }, { "name": "Mazdutide", "sku": "MZ10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 376.87, "url": "https://vestapeptides.com/products/mazdutide-mz10/" } ], "references": [ { "pmid": "42875732", "title": "The GLP-1R/GCGR Dual Agonist Mazdutide Attenuates Liver Steatosis and Decreases Circulating Cholesterol Levels in Mice With Metabolic Dysfunction-Associated Steatotic Liver Disease.", "journal": "Diabetes Obes Metab", "year": "2026" }, { "pmid": "41901218", "title": "Mazdutide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Endoplasmic Reticulum Stress, Improving Lipid Metabolism and Alleviating Inflammation.", "journal": "Pharmaceuticals (Basel)", "year": "2026" } ] }, { "id": "melanotan-i", "name": "Melanotan I", "aliases": [ "Afamelanotide", "NDP-MSH" ], "type": "peptide", "researchArea": "melanocortin-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C78H111N21O19", "formulaScope": "compound", "monoisotopicMass": 1645.8365, "averageMass": 1646.85, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "75921-69-6" ], "pubchemCid": 16197727, "url": "https://vestapeptides.com/compounds/melanotan-i/", "listings": [ { "name": "Melanotan I/II", "sku": "MT-1/MT-2", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/melanotan-i-ii-mt-1-mt-2/" } ], "references": [ { "pmid": "28063031", "title": "Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.", "journal": "Clin Pharmacokinet", "year": "2017" } ] }, { "id": "melanotan-ii", "name": "Melanotan II", "aliases": [ "MT-II" ], "type": "peptide", "researchArea": "melanocortin-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C50H69N15O9", "formulaScope": "compound", "monoisotopicMass": 1023.5403, "averageMass": 1024.18, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "121062-08-6" ], "pubchemCid": 92432, "url": "https://vestapeptides.com/compounds/melanotan-ii/", "listings": [ { "name": "Melanotan I/II", "sku": "MT-1/MT-2", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/melanotan-i-ii-mt-1-mt-2/" } ], "references": [ { "pmid": "7983590", "title": "Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide.", "journal": "J Pharm Sci", "year": "1994" }, { "pmid": "35188390", "title": "CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.", "journal": "J Med Chem", "year": "2022" } ] }, { "id": "mots-c", "name": "MOTS-c", "aliases": [ "Mitochondrial open reading frame of the 12S rRNA-c" ], "type": "peptide", "researchArea": "mitochondria-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C101H152N28O22S2", "formulaScope": "compound", "monoisotopicMass": 2173.1077, "averageMass": 2174.59, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "1627580-64-6" ], "pubchemCid": 146675088, "url": "https://vestapeptides.com/compounds/mots-c/", "listings": [ { "name": "MOTS-c", "sku": "MS10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 95.15, "url": "https://vestapeptides.com/products/mots-c-ms10/" }, { "name": "MOTS-c", "sku": "MS15", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 126.87, "url": "https://vestapeptides.com/products/mots-c-ms15/" }, { "name": "MOTS-c", "sku": "MS20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 158.58, "url": "https://vestapeptides.com/products/mots-c-ms20/" }, { "name": "MOTS-c", "sku": "MS40", "strengthPerVial": "40 mg", "vialsPerKit": 10, "priceUsd": 287.31, "url": "https://vestapeptides.com/products/mots-c-ms40/" } ], "references": [ { "pmid": "25738459", "title": "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.", "journal": "Cell Metab", "year": "2015" }, { "pmid": "33473109", "title": "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.", "journal": "Nat Commun", "year": "2021" }, { "pmid": "36761202", "title": "MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.", "journal": "Front Endocrinol (Lausanne)", "year": "2023" } ] }, { "id": "nad", "name": "NAD+", "aliases": [ "Nicotinamide adenine dinucleotide", "Diphosphopyridine nucleotide" ], "type": "small-molecule", "researchArea": "metabolites-and-small-molecules", "components": [], "declaredTotalMgPerVial": null, "formula": "C21H27N7O14P2", "formulaScope": "compound", "monoisotopicMass": 663.1091, "averageMass": 663.43, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "53-84-9", "64417-72-7" ], "pubchemCid": 5892, "url": "https://vestapeptides.com/compounds/nad/", "listings": [ { "name": "NAD+", "sku": "NJ500", "strengthPerVial": "500 mg", "vialsPerKit": 10, "priceUsd": 52.24, "url": "https://vestapeptides.com/products/nad-nj500/" }, { "name": "NAD+", "sku": "NJ1000", "strengthPerVial": "1000 mg", "vialsPerKit": 10, "priceUsd": 82.09, "url": "https://vestapeptides.com/products/nad-nj1000/" } ], "references": [ { "pmid": "33353981", "title": "NAD(+) metabolism and its roles in cellular processes during ageing.", "journal": "Nat Rev Mol Cell Biol", "year": "2021" }, { "pmid": "39026037", "title": "Regulation of and challenges in targeting NAD(+) metabolism.", "journal": "Nat Rev Mol Cell Biol", "year": "2024" } ] }, { "id": "oxytocin", "name": "Oxytocin", "aliases": [], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C43H66N12O12S2", "formulaScope": "compound", "monoisotopicMass": 1006.4365, "averageMass": 1007.19, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "50-56-6" ], "pubchemCid": 439302, "url": "https://vestapeptides.com/compounds/oxytocin/", "listings": [ { "name": "Oxytocin", "sku": "OT/OXY", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 44.78, "url": "https://vestapeptides.com/products/oxytocin-ot-oxy/" }, { "name": "Oxytocin", "sku": "OT/OXY-10MG", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 57.84, "url": "https://vestapeptides.com/products/oxytocin-ot-oxy-10mg/" } ], "references": [ { "pmid": "29897293", "title": "The Oxytocin Receptor: From Intracellular Signaling to Behavior.", "journal": "Physiol Rev", "year": "2018" }, { "pmid": "32912963", "title": "Is Oxytocin \"Nature's Medicine\"?", "journal": "Pharmacol Rev", "year": "2020" } ] }, { "id": "pe-22-28", "name": "PE-22-28", "aliases": [ "Mini-spadin", "Spadin analogue" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C35H55N11O9", "formulaScope": "compound", "monoisotopicMass": 773.4184, "averageMass": 773.88, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "1801959-12-5" ], "pubchemCid": 165437303, "url": "https://vestapeptides.com/compounds/pe-22-28/", "listings": [ { "name": "PE-22-28", "sku": "PE5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 63.43, "url": "https://vestapeptides.com/products/pe-22-28-pe5/" }, { "name": "PE-22-28", "sku": "PE10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 97.01, "url": "https://vestapeptides.com/products/pe-22-28-pe10/" } ], "references": [ { "pmid": "20405001", "title": "Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.", "journal": "PLoS Biol", "year": "2010" } ] }, { "id": "pt-141", "name": "PT-141", "aliases": [ "Bremelanotide" ], "type": "peptide", "researchArea": "melanocortin-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C50H68N14O10", "formulaScope": "compound", "monoisotopicMass": 1024.5243, "averageMass": 1025.16, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "189691-06-3" ], "pubchemCid": 9941379, "url": "https://vestapeptides.com/compounds/pt-141/", "listings": [ { "name": "PT141", "sku": "p41", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 119.4, "url": "https://vestapeptides.com/products/pt141-p41/" } ], "references": [ { "pmid": "15134289", "title": "PT-141 Palatin.", "journal": "Curr Opin Investig Drugs", "year": "2004" } ] }, { "id": "retatrutide", "name": "Retatrutide", "aliases": [ "LY3437943" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "no public record", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/retatrutide/", "listings": [ { "name": "Retatrutide", "sku": "RT5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 39.18, "url": "https://vestapeptides.com/products/retatrutide-rt5/" }, { "name": "Retatrutide", "sku": "RT10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/retatrutide-rt10/" }, { "name": "Retatrutide", "sku": "RT15", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 97.01, "url": "https://vestapeptides.com/products/retatrutide-rt15/" }, { "name": "Retatrutide", "sku": "RT20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 113.81, "url": "https://vestapeptides.com/products/retatrutide-rt20/" }, { "name": "Retatrutide", "sku": "RT30", "strengthPerVial": "30 mg", "vialsPerKit": 10, "priceUsd": 152.99, "url": "https://vestapeptides.com/products/retatrutide-rt30/" }, { "name": "Retatrutide", "sku": "RT40", "strengthPerVial": "40 mg", "vialsPerKit": 10, "priceUsd": 194.03, "url": "https://vestapeptides.com/products/retatrutide-rt40/" }, { "name": "Retatrutide", "sku": "RT50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 246.27, "url": "https://vestapeptides.com/products/retatrutide-rt50/" }, { "name": "Retatrutide", "sku": "RT60", "strengthPerVial": "60 mg", "vialsPerKit": 10, "priceUsd": 283.58, "url": "https://vestapeptides.com/products/retatrutide-rt60/" }, { "name": "Retatrutide", "sku": "RT80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 317.16, "url": "https://vestapeptides.com/products/retatrutide-rt80/" }, { "name": "Retatrutide", "sku": "RT100", "strengthPerVial": "100 mg", "vialsPerKit": 10, "priceUsd": 380.6, "url": "https://vestapeptides.com/products/retatrutide-rt100/" }, { "name": "Retatrutide", "sku": "RT120", "strengthPerVial": "120 mg", "vialsPerKit": 10, "priceUsd": 451.49, "url": "https://vestapeptides.com/products/retatrutide-rt120/" }, { "name": "Retatrutide+Tirzepatide", "sku": "RET60", "strengthPerVial": "60 mg", "vialsPerKit": 10, "priceUsd": 305.97, "url": "https://vestapeptides.com/products/retatrutide-tirzepatide-ret60/" } ], "references": [ { "pmid": "37178114", "title": "Differentiation of human subcutaneous adipocytes and measurement of lipolytic function induced by GIP or LY3437943.", "journal": "STAR Protoc", "year": "2023" }, { "pmid": "39515565", "title": "The power of three: Retatrutide's role in modern obesity and diabetes therapy.", "journal": "Eur J Pharmacol", "year": "2024" } ] }, { "id": "selank", "name": "Selank", "aliases": [ "TP-7" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C33H57N11O9", "formulaScope": "compound", "monoisotopicMass": 751.4341, "averageMass": 751.87, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "129954-34-3" ], "pubchemCid": 11765600, "url": "https://vestapeptides.com/compounds/selank/", "listings": [ { "name": "Selank", "sku": "SK5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 55.97, "url": "https://vestapeptides.com/products/selank-sk5/" }, { "name": "Selank", "sku": "SK10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 80.22, "url": "https://vestapeptides.com/products/selank-sk10/" }, { "name": "Semax10mg+Selank10mg", "sku": "XS20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 160.45, "url": "https://vestapeptides.com/products/semax10mg-selank10mg-xs20/" } ], "references": [ { "pmid": "36322304", "title": "Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.", "journal": "Bull Exp Biol Med", "year": "2022" }, { "pmid": "32342318", "title": "Functional Connectomic Approach to Studying Selank and Semax Effects.", "journal": "Dokl Biol Sci", "year": "2020" } ] }, { "id": "semaglutide", "name": "Semaglutide", "aliases": [ "NN9535", "Semaglutide acylated GLP-1 analogue" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C187H291N45O59", "formulaScope": "compound", "monoisotopicMass": 4111.1154, "averageMass": 4113.58, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "910463-68-2" ], "pubchemCid": 56843331, "url": "https://vestapeptides.com/compounds/semaglutide/", "listings": [ { "name": "Semaglutide", "sku": "SM5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 29.85, "url": "https://vestapeptides.com/products/semaglutide-sm5/" }, { "name": "Semaglutide", "sku": "SM10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 42.91, "url": "https://vestapeptides.com/products/semaglutide-sm10/" }, { "name": "Semaglutide", "sku": "SM15", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 61.57, "url": "https://vestapeptides.com/products/semaglutide-sm15/" }, { "name": "Semaglutide", "sku": "SM20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 70.9, "url": "https://vestapeptides.com/products/semaglutide-sm20/" }, { "name": "Semaglutide", "sku": "SM30", "strengthPerVial": "30 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/semaglutide-sm30/" }, { "name": "Semaglutide", "sku": "SM40", "strengthPerVial": "40 mg", "vialsPerKit": 10, "priceUsd": 134.33, "url": "https://vestapeptides.com/products/semaglutide-sm40/" }, { "name": "Semaglutide", "sku": "SM50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 156.72, "url": "https://vestapeptides.com/products/semaglutide-sm50/" } ], "references": [ { "pmid": "26308095", "title": "Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.", "journal": "J Med Chem", "year": "2015" }, { "pmid": "31031702", "title": "The Discovery and Development of Liraglutide and Semaglutide.", "journal": "Front Endocrinol (Lausanne)", "year": "2019" }, { "pmid": "32213703", "title": "Semaglutide lowers body weight in rodents via distributed neural pathways.", "journal": "JCI Insight", "year": "2020" } ] }, { "id": "semax", "name": "Semax", "aliases": [ "ACTH(4-10)Pro-Gly-Pro" ], "type": "peptide", "researchArea": "neuropeptide-derived-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C37H51N9O10S", "formulaScope": "compound", "monoisotopicMass": 813.348, "averageMass": 813.92, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "80714-61-0" ], "pubchemCid": 9811102, "url": "https://vestapeptides.com/compounds/semax/", "listings": [ { "name": "Semax", "sku": "XA5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 55.97, "url": "https://vestapeptides.com/products/semax-xa5/" }, { "name": "Semax", "sku": "XA10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 80.22, "url": "https://vestapeptides.com/products/semax-xa10/" }, { "name": "Semax10mg+Selank10mg", "sku": "XS20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 160.45, "url": "https://vestapeptides.com/products/semax10mg-selank10mg-xs20/" } ], "references": [ { "pmid": "17278839", "title": "Specific binding of semax in different regions of the rat brain.", "journal": "Dokl Biol Sci", "year": "2006" }, { "pmid": "15088389", "title": "Effects of Semax on dopaminergic and serotoninergic systems of the brain.", "journal": "Dokl Biol Sci", "year": "2004" } ] }, { "id": "sermorelin", "name": "Sermorelin", "aliases": [ "GRF(1-29)", "GHRH(1-29)NH2" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C149H246N44O42S", "formulaScope": "compound", "monoisotopicMass": 3355.8187, "averageMass": 3357.88, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "86168-78-7" ], "pubchemCid": 16132413, "url": "https://vestapeptides.com/compounds/sermorelin/", "listings": [ { "name": "Sermorelin", "sku": "SM05", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 98.88, "url": "https://vestapeptides.com/products/sermorelin-sm05/" }, { "name": "Sermorelin", "sku": "SM010", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 160.45, "url": "https://vestapeptides.com/products/sermorelin-sm010/" }, { "name": "Sermorelin", "sku": "SM020", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 289.18, "url": "https://vestapeptides.com/products/sermorelin-sm020/" } ], "references": [ { "pmid": "34665524", "title": "Advances in the detection of growth hormone releasing hormone synthetic analogs.", "journal": "Drug Test Anal", "year": "2021" }, { "pmid": "1829020", "title": "A comparison of the biological activities of authentic rat GRF(1-43)OH with the analogue rat GRF(1-29)NH2.", "journal": "Can J Physiol Pharmacol", "year": "1991" } ] }, { "id": "slu-pp-332", "name": "SLU-PP-332", "aliases": [ "ERR agonist SLU-PP-332" ], "type": "small-molecule", "researchArea": "metabolites-and-small-molecules", "components": [], "declaredTotalMgPerVial": null, "formula": "C18H14N2O2", "formulaScope": "compound", "monoisotopicMass": 290.1055, "averageMass": 290.32, "identityBasis": "PubChem", "cas": [ "303760-60-3" ], "pubchemCid": 5338394, "url": "https://vestapeptides.com/compounds/slu-pp-332/", "listings": [ { "name": "SLU-PP-332", "sku": "PP332", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/slu-pp-332-pp332/" } ], "references": [ { "pmid": "37739806", "title": "A Synthetic ERR Agonist Alleviates Metabolic Syndrome.", "journal": "J Pharmacol Exp Ther", "year": "2024" }, { "pmid": "41588687", "title": "In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.", "journal": "Rapid Commun Mass Spectrom", "year": "2026" } ] }, { "id": "ss-31", "name": "SS-31", "aliases": [ "Elamipretide", "MTP-131" ], "type": "peptide", "researchArea": "mitochondria-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C32H49N9O5", "formulaScope": "compound", "monoisotopicMass": 639.3857, "averageMass": 639.79, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "736992-21-5" ], "pubchemCid": 11764719, "url": "https://vestapeptides.com/compounds/ss-31/", "listings": [ { "name": "SS-31", "sku": "2S5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 67.16, "url": "https://vestapeptides.com/products/ss-31-2s5/" }, { "name": "SS-31", "sku": "2S10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 104.48, "url": "https://vestapeptides.com/products/ss-31-2s10/" }, { "name": "SS-31", "sku": "2S50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 354.48, "url": "https://vestapeptides.com/products/ss-31-2s50/" } ], "references": [ { "pmid": "39940712", "title": "Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.", "journal": "Int J Mol Sci", "year": "2025" }, { "pmid": "35037146", "title": "Targeting mitochondrial dysfunction with elamipretide.", "journal": "Heart Fail Rev", "year": "2022" } ] }, { "id": "survodutide", "name": "Survodutide", "aliases": [ "BI 456906" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C192H289N47O61", "formulaScope": "compound", "monoisotopicMass": 4229.0957, "averageMass": 4231.63, "identityBasis": "PubChem", "cas": [ "2805997-46-8" ], "pubchemCid": 171378821, "url": "https://vestapeptides.com/compounds/survodutide/", "listings": [ { "name": "Survodutide", "sku": "SUR10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 291.04, "url": "https://vestapeptides.com/products/survodutide-sur10/" } ], "references": [ { "pmid": "38560764", "title": "The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.", "journal": "Diabetes Obes Metab", "year": "2024" }, { "pmid": "41638399", "title": "Survodutide acts through circumventricular organs in the brain and activates neuronal regions associated with appetite regulation.", "journal": "Mol Metab", "year": "2026" } ] }, { "id": "tesamorelin", "name": "Tesamorelin", "aliases": [ "TH9507" ], "type": "peptide", "researchArea": "growth-hormone-axis-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C221H366N72O67S", "formulaScope": "compound", "monoisotopicMass": 5132.7166, "averageMass": 5135.78, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "218949-48-5", "804475-66-9" ], "pubchemCid": 16137828, "url": "https://vestapeptides.com/compounds/tesamorelin/", "listings": [ { "name": "Tesamorelin", "sku": "TSM5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 115.67, "url": "https://vestapeptides.com/products/tesamorelin-tsm5/" }, { "name": "Tesamorelin", "sku": "TSM10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 197.76, "url": "https://vestapeptides.com/products/tesamorelin-tsm10/" }, { "name": "Tesamorelin", "sku": "TSM20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 363.81, "url": "https://vestapeptides.com/products/tesamorelin-tsm20/" }, { "name": "Tesamorelin10mg+Ipamorelin5mg", "sku": "TI", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/tesamorelin10mg-ipamorelin5mg-ti/" } ], "references": [ { "pmid": "21283099", "title": "Tesamorelin.", "journal": "Nat Rev Drug Discov", "year": "2011" }, { "pmid": "34665524", "title": "Advances in the detection of growth hormone releasing hormone synthetic analogs.", "journal": "Drug Test Anal", "year": "2021" }, { "pmid": "37806509", "title": "Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.", "journal": "Anal Biochem", "year": "2023" } ] }, { "id": "thymalin", "name": "Thymalin", "aliases": [ "Thymalin peptide complex", "Thymic peptide fraction" ], "type": "peptide-fraction", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": null, "formulaScope": "compound", "monoisotopicMass": null, "averageMass": null, "identityBasis": "mixture; component data from PubChem", "cas": [], "pubchemCid": null, "url": "https://vestapeptides.com/compounds/thymalin/", "listings": [ { "name": "Thymalin/Thymulin", "sku": "TY10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 108.21, "url": "https://vestapeptides.com/products/thymalin-thymulin-ty10/" } ], "references": [ { "pmid": "37686182", "title": "The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19.", "journal": "Int J Mol Sci", "year": "2023" }, { "pmid": "33237528", "title": "Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells.", "journal": "Bull Exp Biol Med", "year": "2020" }, { "pmid": "12447484", "title": "Age-related changes of thymalin content in human epidermis.", "journal": "Bull Exp Biol Med", "year": "2002" } ] }, { "id": "thymosin-alpha-1", "name": "Thymosin alpha 1", "aliases": [ "Thymalfasin", "Tα1" ], "type": "peptide", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C129H215N33O55", "formulaScope": "compound", "monoisotopicMass": 3106.5041, "averageMass": 3108.28, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "62304-98-7", "69521-94-4", "1337515-90-8" ], "pubchemCid": 16130571, "url": "https://vestapeptides.com/compounds/thymosin-alpha-1/", "listings": [ { "name": "Thymosin alpha 1", "sku": "TA5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 126.87, "url": "https://vestapeptides.com/products/thymosin-alpha-1-ta5/" }, { "name": "Thymosin alpha 1", "sku": "TA10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 216.42, "url": "https://vestapeptides.com/products/thymosin-alpha-1-ta10/" } ], "references": [ { "pmid": "36207535", "title": "Identification and determination of structurally related peptide impurities in thymalfasin by liquid chromatography-high-resolution mass spectrometry.", "journal": "Anal Bioanal Chem", "year": "2022" }, { "pmid": "11381492", "title": "Thymosin alpha-1.", "journal": "Am J Health Syst Pharm", "year": "2001" } ] }, { "id": "thymosin-beta-4", "name": "Thymosin beta-4 (TB-500)", "aliases": [ "TB-500", "TB500", "Tβ4", "Thymosin beta 4" ], "type": "peptide", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C212H350N56O78S", "formulaScope": "compound", "monoisotopicMass": 4960.4863, "averageMass": 4963.44, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [], "pubchemCid": 45382195, "url": "https://vestapeptides.com/compounds/thymosin-beta-4/", "listings": [ { "name": "TB500", "sku": "TB5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 113.81, "url": "https://vestapeptides.com/products/tb500-tb5/" }, { "name": "TB500", "sku": "TB10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 197.76, "url": "https://vestapeptides.com/products/tb500-tb10/" }, { "name": "TB500", "sku": "TB20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 354.48, "url": "https://vestapeptides.com/products/tb500-tb20/" }, { "name": "GLOW", "sku": "Glow70", "strengthPerVial": "70 mg", "vialsPerKit": 10, "priceUsd": 208.96, "url": "https://vestapeptides.com/products/glow-glow70/" }, { "name": "Klow", "sku": "Klow80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 253.73, "url": "https://vestapeptides.com/products/klow-klow80/" } ], "references": [ { "pmid": "4088087", "title": "Thymosin beta 4.", "journal": "Methods Enzymol", "year": "1985" }, { "pmid": "29502471", "title": "Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations.", "journal": "Expert Opin Biol Ther", "year": "2018" }, { "pmid": "38994967", "title": "Thymosin β(4) and β(10) Expression in Human Organs during Development: A Review.", "journal": "Cells", "year": "2024" } ] }, { "id": "thymulin", "name": "Thymulin", "aliases": [ "Facteur thymique sérique", "FTS", "Zinc thymulin" ], "type": "peptide", "researchArea": "short-regulatory-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C33H54N12O15", "formulaScope": "compound", "monoisotopicMass": 858.3832, "averageMass": 858.85, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "78922-62-0" ], "pubchemCid": 71300623, "url": "https://vestapeptides.com/compounds/thymulin/", "listings": [ { "name": "Thymalin/Thymulin", "sku": "TY10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 108.21, "url": "https://vestapeptides.com/products/thymalin-thymulin-ty10/" } ], "references": [ { "pmid": "2657247", "title": "Thymulin, a zinc-dependent hormone.", "journal": "Med Oncol Tumor Pharmacother", "year": "1989" }, { "pmid": "7681212", "title": "Biochemical and biological aspects of the interaction between thymulin and zinc.", "journal": "Prog Clin Biol Res", "year": "1993" }, { "pmid": "3878920", "title": "Thymulin.", "journal": "Methods Enzymol", "year": "1985" } ] }, { "id": "tirzepatide", "name": "Tirzepatide", "aliases": [ "LY3298176" ], "type": "peptide", "researchArea": "incretin-related-peptides", "components": [], "declaredTotalMgPerVial": null, "formula": "C225H348N48O68", "formulaScope": "compound", "monoisotopicMass": 4810.5249, "averageMass": 4813.45, "identityBasis": "sequence-calculated and matched to PubChem", "cas": [ "2023788-19-2" ], "pubchemCid": 166567236, "url": "https://vestapeptides.com/compounds/tirzepatide/", "listings": [ { "name": "Tirzepatide", "sku": "TR5", "strengthPerVial": "5 mg", "vialsPerKit": 10, "priceUsd": 31.72, "url": "https://vestapeptides.com/products/tirzepatide-tr5/" }, { "name": "Tirzepatide", "sku": "TR10", "strengthPerVial": "10 mg", "vialsPerKit": 10, "priceUsd": 46.64, "url": "https://vestapeptides.com/products/tirzepatide-tr10/" }, { "name": "Tirzepatide", "sku": "TR15", "strengthPerVial": "15 mg", "vialsPerKit": 10, "priceUsd": 61.57, "url": "https://vestapeptides.com/products/tirzepatide-tr15/" }, { "name": "Tirzepatide", "sku": "TR20", "strengthPerVial": "20 mg", "vialsPerKit": 10, "priceUsd": 82.09, "url": "https://vestapeptides.com/products/tirzepatide-tr20/" }, { "name": "Tirzepatide", "sku": "TR30", "strengthPerVial": "30 mg", "vialsPerKit": 10, "priceUsd": 111.94, "url": "https://vestapeptides.com/products/tirzepatide-tr30/" }, { "name": "Tirzepatide", "sku": "TR40", "strengthPerVial": "40 mg", "vialsPerKit": 10, "priceUsd": 134.33, "url": "https://vestapeptides.com/products/tirzepatide-tr40/" }, { "name": "Tirzepatide", "sku": "TR50", "strengthPerVial": "50 mg", "vialsPerKit": 10, "priceUsd": 171.64, "url": "https://vestapeptides.com/products/tirzepatide-tr50/" }, { "name": "Tirzepatide", "sku": "TR60", "strengthPerVial": "60 mg", "vialsPerKit": 10, "priceUsd": 197.76, "url": "https://vestapeptides.com/products/tirzepatide-tr60/" }, { "name": "Tirzepatide", "sku": "TR80", "strengthPerVial": "80 mg", "vialsPerKit": 10, "priceUsd": 250, "url": "https://vestapeptides.com/products/tirzepatide-tr80/" }, { "name": "Tirzepatide", "sku": "TR100", "strengthPerVial": "100 mg", "vialsPerKit": 10, "priceUsd": 298.51, "url": "https://vestapeptides.com/products/tirzepatide-tr100/" }, { "name": "Tirzepatide", "sku": "TR120", "strengthPerVial": "120 mg", "vialsPerKit": 10, "priceUsd": 354.48, "url": "https://vestapeptides.com/products/tirzepatide-tr120/" }, { "name": "Retatrutide+Tirzepatide", "sku": "RET60", "strengthPerVial": "60 mg", "vialsPerKit": 10, "priceUsd": 305.97, "url": "https://vestapeptides.com/products/retatrutide-tirzepatide-ret60/" } ], "references": [ { "pmid": "32730231", "title": "Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.", "journal": "JCI Insight", "year": "2020" }, { "pmid": "36498958", "title": "Tirzepatide: A Systematic Update.", "journal": "Int J Mol Sci", "year": "2022" } ] } ] }